Ekso Bionics to Provide Corporate Update and Host Second Quarter Call on Thursday, August 7, 2014
July 31 2014 - 7:00AM
Ekso Bionics Holdings, Inc. (OTCQB:EKSO), a robotic exoskeleton
company, today announced that it will hold a conference call and
audio webcast to discuss quarterly results for its second quarter
2014 and provide a general business update on Thursday, August 7,
2014 at 4:30pm ET.
Conference call and webcast
details: |
Date: August 7, 2014 |
Time: 4:30pm ET |
Listen via Internet:
http://eksobionics.equisolvewebcast.com/q2-2014 |
Dial-In Toll-free (US and Canada):
877-407-3036 |
Dial-In (International): 201-689-8335 |
A webcast replay will be available on the
Ekso Bionics website for 30 days. |
About Ekso Bionics (OTCQB:EKSO)
Since 2005, Ekso Bionics (http://www.eksobionics.com) has been
pioneering the field of robotic exoskeletons, or wearable robots,
to augment human strength, endurance and mobility. The company's
first commercially available product called Ekso has helped
thousands of people living with paralysis take millions of steps
not otherwise possible. By designing and creating some of the most
forward-thinking and innovative solutions for people looking to
augment human capabilities, Ekso Bionics is helping people rethink
current physical limitations and achieve the remarkable.
Facebook: www.facebook.com/eksobionics Twitter: @eksobionics
YouTube: http://www.youtube.com/user/EksoBionics/
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Forward-looking statements may include, without
limitation, statements regarding (i) the plans and objectives of
management for future operations, including plans or objectives
relating to the design, development and commercialization of human
exoskeletons, (ii) a projection of income (including income/loss),
earnings (including earnings/loss) per share, capital expenditures,
dividends, capital structure or other financial items, (iii) the
Company's future financial performance and (iv) the assumptions
underlying or relating to any statement described in points (i),
(ii) or (iii) above. Such forward-looking statements are not
meant to predict or guarantee actual results, performance, events
or circumstances and may not be realized because they are based
upon the Company's current projections, plans, objectives, beliefs,
expectations, estimates and assumptions and are subject to a number
of risks and uncertainties and other influences, many of which the
Company has no control over. Actual results and the timing of
certain events and circumstances may differ materially from those
described by the forward-looking statements as a result of these
risks and uncertainties. Factors that may influence or
contribute to the inaccuracy of the forward-looking statements or
cause actual results to differ materially from expected or desired
results may include, without limitation, the Company's inability to
obtain adequate financing, the significant length of time and
resources associated with the development of our products and
related insufficient cash flows and resulting illiquidity, the
Company's inability to expand the Company's business, significant
government regulation of medical devices and the healthcare
industry, lack of product diversification, volatility in the price
of the Company's raw materials, existing or increased competition,
results of arbitration and litigation, stock volatility and
illiquidity, and the Company's failure to implement the Company's
business plans or strategies. These and other factors are
identified and described in more detail in the Company's filings
with the SEC, including, the Company's Current Report on Form 8-K
filed on March 31, 2014 and the Company's latest Form 10-Q filed on
May 13, 2014. The Company does not undertake to update these
forward-looking statements.
CONTACT: Media Contact:
Heidi Darling, Marketing Manager
Phone: 415.302.4777
hdarling@eksobionics.com
Investor Contact:
Lauren Glaser, Vice President
Phone: 646.378.2972
lglaser@troutgroup.com
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ekso Bionics (NASDAQ:EKSO)
Historical Stock Chart
From Apr 2023 to Apr 2024